Clinical Trial Update: Safety and Efficacy of BFH772 in Psoriasis Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update reports safety and efficacy data for BFH772 in patients with psoriasis and arthritis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Psoriasis

Drugs mentioned

• BFH772

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Psoriasis, Arthritis | Phase 1, Phase 2 | Status: COMPLETED